Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis

The association between non-steroidal anti-inflammatory drugs (NSAIDs) use and breast cancer has remained controversial. Therefore, an overall quantitative estimate of the association needs to be studied. A systematic review and meta-analysis was executed to explore the pooled estimate for relative risk (RR) and 95% confidence interval (CI) using random or fixed effects models based on heterogeneity analysis. Overall 26 studies with 528,705 participants were included. The RR of NSAIDs use and the incidence of breast cancer was 0.94 (95% CI: 0.88–1.00) with random effects model. A slight reduction of breast cancer by taking aspirin and ibuprofen was both observed with pooled RR of 0.91 (95% CI: 0.83–0.98) and 0.81 (95% CI: 0.67–0.97), respectively. Our results indicate that NSAIDs use is associated with a slight decrease for the development of breast cancer with a marginally statistical significant difference. The associations are slightly more obvious in aspirin and ibuprofen use.

[1]  M. Thun,et al.  Risk factors for self-reported colon polyps , 1998, Journal of General Internal Medicine.

[2]  L. G. García Rodríguez,et al.  Risk of breast cancer among users of aspirin and other anti-inflammatory drugs , 2004, British Journal of Cancer.

[3]  M. Cotterchio,et al.  Nonsteroidal anti-inflammatory drug use and breast cancer risk. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  Genetic polymorphisms in the cyclooxygenase-2 gene, use of nonsteroidal anti-inflammatory drugs, and breast cancer risk , 2006, Breast Cancer Research.

[5]  M. Thun,et al.  Aspirin use and risk of fatal cancer. , 1993, Cancer research.

[6]  A. Folsom,et al.  Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  M. Thun,et al.  Association of Polymorphisms in the Paraoxonase 1 Gene with Breast Cancer Incidence in the CPS-II Nutrition Cohort , 2006, Cancer Epidemiology Biomarkers & Prevention.

[8]  R. Makuch,et al.  Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.

[9]  U. Vogel,et al.  Peroxisome proliferator-activated [corrected] receptor-gamma2 [corrected] Pro12Ala, interaction with alcohol intake and NSAID use, in relation to risk of breast cancer in a prospective study of Danes. , 2006, Carcinogenesis.

[10]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[11]  F. Robertson,et al.  Cyclooxygenase-2 gene expression in human breast cancer. , 1997, International journal of oncology.

[12]  N. Petrelli,et al.  Aspirin use, cancer, and polyps of the large bowel , 1993, Cancer.

[13]  J. Watson,et al.  Prostaglandins, steroids and human mammary cancer. , 1985, European journal of cancer & clinical oncology.

[14]  H. Ury,et al.  Initial screening for carcinogenicity of commonly used drugs. , 1980, Journal of the National Cancer Institute.

[15]  W. Farrar,et al.  Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. , 1999, Oncology reports.

[16]  Harukazu Tsuruta,et al.  Development and validation of MIX: comprehensive free software for meta-analysis of causal research data , 2006, BMC medical research methodology.

[17]  P. Loehrer Long-term Use of Aspirin and Nonsteroidal Anti-inflammatory Drugs and Risk of Colorectal Cancer , 2007 .

[18]  R. Lancashire,et al.  Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database , 2000, BMJ : British Medical Journal.

[19]  I. Sartori Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals. , 1996 .

[20]  J. Barkin The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force , 2008 .

[21]  Randall Harris,et al.  Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies. , 2007, Sub-cellular biochemistry.

[22]  J. Ghosn,et al.  Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer , 2005, BMC Cancer.

[23]  Randall Harris,et al.  Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors , 2006, BMC Cancer.

[24]  L F Watson,et al.  Colorectal cancer risk, chronic illnesses, operations and medications: case control results from the Melbourne Colorectal Cancer Study. 1988. , 2007, International journal of epidemiology.

[25]  U. Vogel,et al.  Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[26]  K. Helzlsouer,et al.  Nonsteroidal antiinflammatory drugs, cyclooxygenase polymorphisms, and the risk of developing breast carcinoma among women with benign breast disease , 2006, Cancer.

[27]  K. Namboodiri,et al.  Breast cancer and NSAID use: heterogeneity of effect in a case-control study. , 1995, Preventive medicine.

[28]  A. McTiernan,et al.  NSAID use and breast cancer risk in the VITAL cohort , 2008, Breast Cancer Research and Treatment.

[29]  D F Roychowdhury,et al.  Aspirin and the risk of colorectal cancer in women. , 1996, The New England journal of medicine.

[30]  R Day,et al.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[31]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[32]  S. Neuhausen,et al.  Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  B. Henderson,et al.  Aspirin use and chronic diseases: a cohort study of the elderly. , 1989, BMJ.

[34]  A. Folsom,et al.  NSAID use and survival after breast cancer diagnosis in post-menopausal women , 2006, Breast Cancer Research and Treatment.

[35]  S Duval,et al.  Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis , 2000, Biometrics.

[36]  R. Millikan,et al.  Cyclooxygenase 2 Polymorphism (Val511Ala), Nonsteroidal Anti-inflammatory Drug Use and Breast Cancer in African American Women , 2005, Cancer Epidemiology Biomarkers & Prevention.

[37]  A. Neugut,et al.  MnSOD Val-9Ala Genotype, Pro- and Anti-oxidant Environmental Modifiers, and Breast Cancer Among Women on Long Island, New York , 2005, Cancer Causes & Control.

[38]  L. Rosenberg Nonsteroidal anti-inflammatory drugs and cancer. , 1995, Preventive medicine.

[39]  Sowmya R. Rao,et al.  The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer. , 1999, Preventive medicine.

[40]  M. Thun,et al.  Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort. , 2005, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[41]  D. Mirick,et al.  Medication use and the risk of breast cancer , 2007, European Journal of Epidemiology.

[42]  H. Sano,et al.  Expression of Cyclooxygenase-1 and -2 in Human Breast Cancer , 2003, Surgery Today.

[43]  M. Cotterchio,et al.  Nonsteroidal antiinflammatory drug use and breast cancer risk: subgroup findings. , 2007, American journal of epidemiology.

[44]  G. Anderson,et al.  Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. , 2003, Cancer research.

[45]  K. Moysich,et al.  Association of Regular Aspirin Use and Breast Cancer Risk , 2005, Oncology.

[46]  K. Helzlsouer,et al.  Nonsteroidal anti‐inflammatory drugs and the risk of developing breast cancer in a population‐based prospective cohort study in Washington County, MD , 2007, International journal of cancer.

[47]  P. Schlattmann,et al.  Aspirin use and breast cancer risk: a meta‐analysis and meta‐regression of observational studies from 2001 to 2005 , 2008, Pharmacoepidemiology and drug safety.

[48]  H. Jick,et al.  Association Between Acetaminophen or Nonsteroidal Antiinflammatory Drugs and Risk of Developing Ovarian, Breast, or Colon Cancer , 2002, Pharmacotherapy.

[49]  A. Neugut,et al.  Association between coronary heart disease and cancers of the breast, prostate, and colon. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[50]  Stephen D. Persell,et al.  Low-Dose Aspirin Does Not Reduce Cancer Incidence in Women Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005;294:47-55. , 2005 .

[51]  T. Byers,et al.  IL6, Aspirin, Nonsteroidal Anti-inflammatory Drugs, and Breast Cancer Risk in Women Living in the Southwestern United States , 2007, Cancer Epidemiology Biomarkers & Prevention.

[52]  N. Feller,et al.  Prostaglandin E2 and cyclic AMP in tumor and plasma of breast cancer patients , 2004, Journal of Cancer Research and Clinical Oncology.

[53]  J. Palmer,et al.  Use of nonsteroidal antiinflammatory drugs and risk of breast cancer: the Case-Control Surveillance Study revisited. , 2005, American journal of epidemiology.

[54]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[55]  R. Everson,et al.  Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study , 1994, Epidemiology.

[56]  J. Manson,et al.  Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. , 2005, JAMA.

[57]  J. Olsen,et al.  A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin , 2003, British Journal of Cancer.

[58]  J A Hanley,et al.  Nested caseÐcontrol study of the effects of non- steroidal anti-inflammatory drugs on breast cancer risk and stage , 2000 .

[59]  H T Sørensen,et al.  Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study , 2003, British Journal of Cancer.

[60]  G. Colditz,et al.  Prospective study of regular aspirin use and the risk of breast cancer. , 1996, Journal of the National Cancer Institute.

[61]  M. Thun,et al.  A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. , 2007, Journal of the National Cancer Institute.

[62]  D. Stram,et al.  Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. , 2005, Journal of the National Cancer Institute.

[63]  R. Millikan,et al.  Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast , 2003, Cancer Causes & Control.

[64]  S. Khuder,et al.  Breast cancer and NSAID use: a meta-analysis , 2001, British Journal of Cancer.

[65]  L. Habel,et al.  NSAIDs and breast cancer recurrence in a prospective cohort study , 2007, Cancer Causes & Control.

[66]  R. López‐Ridaura,et al.  Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis , 2003, BMC Cancer.

[67]  K. Namboodiri,et al.  Nonsteroidal antiinflammatory drugs and breast cancer. , 1996, Epidemiology.

[68]  M. Pike,et al.  Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort. , 2006, American journal of epidemiology.

[69]  J. Manson,et al.  Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial , 2008, British Journal of Cancer.